Pub. Date : 1995 Nov
PMID : 7583862
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 2 | BACKGROUND/OBJECTIVE: The purpose of this study was to determine whether the addition of extended-release theophylline to the daily treatment regimen of inhaled beta 2-agonist users would result in decreased use of beta 2-agonist while maintaining similar efficacy for treatment of asthma. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 3 | BACKGROUND/OBJECTIVE: The purpose of this study was to determine whether the addition of extended-release theophylline to the daily treatment regimen of inhaled beta 2-agonist users would result in decreased use of beta 2-agonist while maintaining similar efficacy for treatment of asthma. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 4 | In this study, the addition of theophylline to the daily regimen of inhaled beta 2-agonist for 4 weeks significantly reduced the total daily dose of inhaled beta 2-agonist at weeks 3 and 4 of treatment compared with placebo. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 5 | In this study, the addition of theophylline to the daily regimen of inhaled beta 2-agonist for 4 weeks significantly reduced the total daily dose of inhaled beta 2-agonist at weeks 3 and 4 of treatment compared with placebo. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 6 | CONCLUSIONS: In this study, the addition of once daily, extended-release theophylline to the daily regimen of inhaled beta 2-agonist for 4 weeks significantly reduced the total daily dose of inhaled beta 2-agonist at weeks 3 and 4 of treatment compared with placebo, while maintaining acceptable asthma symptom scores. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 7 | CONCLUSIONS: In this study, the addition of once daily, extended-release theophylline to the daily regimen of inhaled beta 2-agonist for 4 weeks significantly reduced the total daily dose of inhaled beta 2-agonist at weeks 3 and 4 of treatment compared with placebo, while maintaining acceptable asthma symptom scores. | Theophylline | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |